|
LOC493754 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.888600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.111400E-01 |
| Normal-vs-Stage2 |
6.673800E-01 |
| Normal-vs-Stage3 |
2.478200E-01 |
| Normal-vs-Stage4 |
1.749620E-01 |
| Stage1-vs-Stage2 |
7.053000E-01 |
| Stage1-vs-Stage3 |
1.762200E-01 |
| Stage1-vs-Stage4 |
1.273980E-01 |
| Stage2-vs-Stage3 |
5.428000E-01 |
| Stage2-vs-Stage4 |
4.009200E-01 |
| Stage3-vs-Stage4 |
7.407200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.069400E-01 |
| Normal-vs-AfricanAmerican |
8.884200E-01 |
| Normal-vs-Asian |
4.908400E-01 |
| Caucasian-vs-AfricanAmerican |
3.631800E-01 |
| Caucasian-vs-Asian |
3.410800E-01 |
| AfricanAmerican-vs-Asian |
5.397000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.776600E-01 |
| Normal-vs-Female |
6.040800E-01 |
| Male-vs-Female |
7.097200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.421800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.568550E-01 |
| Normal-vs-Age(61-80Yrs) |
8.774600E-01 |
| Normal-vs-Age(81-100Yrs) |
5.246600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.933200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.147600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.150400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.022400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.194400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.790000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.602400E-01 |
| Normal-vs-Grade 2 |
9.720800E-01 |
| Normal-vs-Grade 3 |
3.614600E-01 |
| Normal-vs-Grade 4 |
4.348300E-02 |
| Grade 1-vs-Grade 2 |
3.449400E-01 |
| Grade 1-vs-Grade 3 |
2.229600E-01 |
| Grade 1-vs-Grade 4 |
1.030630E-01 |
| Grade 2-vs-Grade 3 |
2.072400E-01 |
| Grade 2-vs-Grade 4 |
1.432080E-02 |
| Grade 3-vs-Grade 4 |
1.417830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.781000E-01 |
| Normal-vs-ccB subtype |
2.328000E-01 |
| ccA subtype-vs-ccB subtype |
4.841900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.269800E-01 |
| Normal-vs-N1 |
2.808200E-01 |
| N0-vs-N1 |
3.421000E-01 |
|
|
